These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 22653043

  • 1. Renalguard system in high-risk patients for contrast-induced acute kidney injury.
    Briguori C.
    Minerva Cardioangiol; 2012 Jun; 60(3):291-7. PubMed ID: 22653043
    [Abstract] [Full Text] [Related]

  • 2. Renal Insufficiency After Contrast Media Administration Trial II (REMEDIAL II): RenalGuard System in high-risk patients for contrast-induced acute kidney injury.
    Briguori C, Visconti G, Focaccio A, Airoldi F, Valgimigli M, Sangiorgi GM, Golia B, Ricciardelli B, Condorelli G, REMEDIAL II Investigators.
    Circulation; 2011 Sep 13; 124(11):1260-9. PubMed ID: 21844075
    [Abstract] [Full Text] [Related]

  • 3. Renal insufficiency following contrast media administration trial II (REMEDIAL II): RenalGuard system in high-risk patients for contrast-induced acute kidney injury: rationale and design.
    Briguori C, Visconti G, Ricciardelli B, Condorelli G, REMEDIAL II Investigators.
    EuroIntervention; 2011 Apr 13; 6(9):1117-22, 7. PubMed ID: 21518686
    [Abstract] [Full Text] [Related]

  • 4. Acute Kidney Injury With the RenalGuard System in Patients Undergoing Transcatheter Aortic Valve Replacement: The PROTECT-TAVI Trial (PROphylactic effecT of furosEmide-induCed diuresis with matched isotonic intravenous hydraTion in Transcatheter Aortic Valve Implantation).
    Barbanti M, Gulino S, Capranzano P, Immè S, Sgroi C, Tamburino C, Ohno Y, Attizzani GF, Patanè M, Sicuso R, Pilato G, Di Landro A, Todaro D, Di Simone E, Picci A, Giannetto G, Costa G, Deste W, Giannazzo D, Grasso C, Capodanno D, Tamburino C.
    JACC Cardiovasc Interv; 2015 Oct 13; 8(12):1595-604. PubMed ID: 26386766
    [Abstract] [Full Text] [Related]

  • 5. Effect of theophylline on prevention of contrast-induced acute kidney injury: a meta-analysis of randomized controlled trials.
    Dai B, Liu Y, Fu L, Li Y, Zhang J, Mei C.
    Am J Kidney Dis; 2012 Sep 13; 60(3):360-70. PubMed ID: 22516682
    [Abstract] [Full Text] [Related]

  • 6. RenalGuard system in high-risk patients for contrast-induced acute kidney injury.
    Briguori C, Visconti G, Donahue M, De Micco F, Focaccio A, Golia B, Signoriello G, Ciardiello C, Donnarumma E, Condorelli G.
    Am Heart J; 2016 Mar 13; 173():67-76. PubMed ID: 26920598
    [Abstract] [Full Text] [Related]

  • 7. Usefulness of N-acetylcysteine or ascorbic acid versus placebo to prevent contrast-induced acute kidney injury in patients undergoing elective cardiac catheterization: a single-center, prospective, randomized, double-blind, placebo-controlled trial.
    Brueck M, Cengiz H, Hoeltgen R, Wieczorek M, Boedeker RH, Scheibelhut C, Boening A.
    J Invasive Cardiol; 2013 Jun 13; 25(6):276-83. PubMed ID: 23735352
    [Abstract] [Full Text] [Related]

  • 8. Feasibility study of the RenalGuard™ balanced hydration system: a novel strategy for the prevention of contrast-induced nephropathy in high risk patients.
    Dorval JF, Dixon SR, Zelman RB, Davidson CJ, Rudko R, Resnic FS.
    Int J Cardiol; 2013 Jun 20; 166(2):482-6. PubMed ID: 22204847
    [Abstract] [Full Text] [Related]

  • 9. RenalGuard System for the prevention of acute kidney injury in patients undergoing transcatheter aortic valve implantation.
    Visconti G, Focaccio A, Donahue M, Golia B, Marzano A, Donnarumma E, Ricciardelli B, Selvetella L, Marino L, Briguori C.
    EuroIntervention; 2016 Apr 08; 11(14):e1658-61. PubMed ID: 27056126
    [Abstract] [Full Text] [Related]

  • 10. Comparison of risk factors for contrast-induced acute kidney injury between patients with and without diabetes.
    Pakfetrat M, Nikoo MH, Malekmakan L, Tabande M, Roozbeh J, Ganbar Ali RJ, Khajehdehi P.
    Hemodial Int; 2010 Oct 08; 14(4):387-92. PubMed ID: 20796046
    [Abstract] [Full Text] [Related]

  • 11. Impact of benazepril on contrast-induced acute kidney injury for patients with mild to moderate renal insufficiency undergoing percutaneous coronary intervention.
    Li XM, Cong HL, Li TT, He LJ, Zhou YJ.
    Chin Med J (Engl); 2011 Jul 08; 124(14):2101-6. PubMed ID: 21933609
    [Abstract] [Full Text] [Related]

  • 12. Renal insufficiency following contrast media administration trial III: Urine flow rate-guided versus left-ventricular end-diastolic pressure-guided hydration in high-risk patients for contrast-induced acute kidney injury. Rationale and design.
    Briguori C, D'Amore C, De Micco F, Signore N, Esposito G, Napolitano G, Focaccio A, REMEDIAL III Investigators.
    Catheter Cardiovasc Interv; 2020 Apr 01; 95(5):895-903. PubMed ID: 31282129
    [Abstract] [Full Text] [Related]

  • 13. RenalGuard system to prevent contrast-induced acute kidney injury in Japanese patients with renal dysfunction; RESPECT KIDNEY study.
    Katoh H, Nozue T, Horie K, Sozu T, Inoue N, Michishita I.
    Cardiovasc Interv Ther; 2019 Apr 01; 34(2):105-112. PubMed ID: 29730853
    [Abstract] [Full Text] [Related]

  • 14. Prevention of postcontrast acute kidney injury after percutaneous transluminal angioplasty by inducing RenalGuard controlled furosemide forced diuresis with matched hydration: study protocol for a randomised controlled trial.
    Bolt LJJ, Sigterman TA, Krasznai AG, Sikkink CJM, Schurink GH, Bouwman LH.
    BMJ Open; 2018 Oct 04; 8(9):e021842. PubMed ID: 30287607
    [Abstract] [Full Text] [Related]

  • 15. Effects of hydration in contrast-induced acute kidney injury after primary angioplasty: a randomized, controlled trial.
    Maioli M, Toso A, Leoncini M, Micheletti C, Bellandi F.
    Circ Cardiovasc Interv; 2011 Oct 01; 4(5):456-62. PubMed ID: 21972403
    [Abstract] [Full Text] [Related]

  • 16. New strategy of α- and γ-tocopherol to prevent contrast-induced acute kidney injury in chronic kidney disease patients undergoing elective coronary procedures.
    Tasanarong A, Vohakiat A, Hutayanon P, Piyayotai D.
    Nephrol Dial Transplant; 2013 Feb 01; 28(2):337-44. PubMed ID: 23314316
    [Abstract] [Full Text] [Related]

  • 17. Persistent renal damage after contrast-induced acute kidney injury: incidence, evolution, risk factors, and prognosis.
    Maioli M, Toso A, Leoncini M, Gallopin M, Musilli N, Bellandi F.
    Circulation; 2012 Jun 26; 125(25):3099-107. PubMed ID: 22592896
    [Abstract] [Full Text] [Related]

  • 18. Prevention of contrast nephropathy by furosemide with matched hydration: the MYTHOS (Induced Diuresis With Matched Hydration Compared to Standard Hydration for Contrast Induced Nephropathy Prevention) trial.
    Marenzi G, Ferrari C, Marana I, Assanelli E, De Metrio M, Teruzzi G, Veglia F, Fabbiocchi F, Montorsi P, Bartorelli AL.
    JACC Cardiovasc Interv; 2012 Jan 26; 5(1):90-7. PubMed ID: 22230154
    [Abstract] [Full Text] [Related]

  • 19. Forced euvolemic diuresis with mannitol and furosemide for prevention of contrast-induced nephropathy in patients with CKD undergoing coronary angiography: a randomized controlled trial.
    Majumdar SR, Kjellstrand CM, Tymchak WJ, Hervas-Malo M, Taylor DA, Teo KK.
    Am J Kidney Dis; 2009 Oct 26; 54(4):602-9. PubMed ID: 19535188
    [Abstract] [Full Text] [Related]

  • 20. [Monocentric experience of the RenalGuard® system to limit post-contrast acute kidney injury in patients at high-risk undergoing interventional coronary procedures].
    Elleuch A, Hebbo A, Steinecker M, Bouaouina MS, Alqudwa A, Ghannem M, Poulos N, Aubry P.
    Ann Cardiol Angeiol (Paris); 2022 Nov 26; 71(5):283-289. PubMed ID: 36115720
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.